166 related articles for article (PubMed ID: 34976929)
1. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
Mahadi AR
Front Public Health; 2021; 9():770593. PubMed ID: 34976929
[No Abstract] [Full Text] [Related]
2. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Sulis G; Sayood S; Gandra S
Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
Nieuwlaat R; Mbuagbaw L; Mertz D; Burrows LL; Bowdish DME; Moja L; Wright GD; Schünemann HJ
Clin Infect Dis; 2021 May; 72(9):1657-1659. PubMed ID: 32544232
[TBL] [Abstract][Full Text] [Related]
7. Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments.
Pruden A; Vikesland PJ; Davis BC; de Roda Husman AM
Curr Opin Microbiol; 2021 Dec; 64():91-99. PubMed ID: 34655936
[TBL] [Abstract][Full Text] [Related]
8. Raising awareness of antimicrobial resistance in rural aquaculture practice in Bangladesh through digital communications: a pilot study.
Thornber K; Huso D; Rahman MM; Biswas H; Rahman MH; Brum E; Tyler CR
Glob Health Action; 2019; 12(sup1):1734735. PubMed ID: 32153258
[TBL] [Abstract][Full Text] [Related]
9. A disparity in the number of studies related to COVID-19 and SARS-CoV-2 between low- and middle-income countries and high-income countries.
Usuzaki T; Chiba S; Shimoyama M; Ishikuro M; Obara T
Int Health; 2021 Jul; 13(4):379-381. PubMed ID: 33130855
[TBL] [Abstract][Full Text] [Related]
10. Treatment of COVID-19: implications for antimicrobial resistance in Africa.
Iwu CJ; Jordan P; Jaja IF; Iwu CD; Wiysonge CS
Pan Afr Med J; 2020; 35(Suppl 2):119. PubMed ID: 33282074
[TBL] [Abstract][Full Text] [Related]
11. Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance.
Kalam A; Shano S; Khan MA; Islam A; Warren N; Hassan MM; Davis M
PLoS One; 2021; 16(12):e0261368. PubMed ID: 34905563
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!
Haqqi A; Awan UA; Ahmed H; Afzal MS
J Formos Med Assoc; 2021 Jul; 120(7):1537-1538. PubMed ID: 33771414
[No Abstract] [Full Text] [Related]
13. Combating antimicrobial resistance during the COVID-19 pandemic.
Ma ESK; Kung KH; Chen H
Hong Kong Med J; 2021 Dec; 27(6):396-398. PubMed ID: 34785620
[No Abstract] [Full Text] [Related]
14. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
[TBL] [Abstract][Full Text] [Related]
15. Women's Knowledge, Attitude, and Perceptions Toward COVID-19 in Lower-Middle-Income Countries: A Representative Cross-Sectional Study in Bangladesh.
Anwar S; Araf Y; Newaz Khan A; Ullah MA; Hoque N; Sarkar B; Reshad RAI; Islam R; Ali N; Hosen MJ
Front Public Health; 2020; 8():571689. PubMed ID: 33313035
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh.
Mahmud-Al-Rafat A; Hewins B; Mannan A; Kelvin DJ; Billah MM
Lancet Infect Dis; 2022 Mar; 22(3):310-312. PubMed ID: 35101243
[No Abstract] [Full Text] [Related]
17. A trade-off: Antimicrobial resistance and COVID-19.
Johnson T
Bioethics; 2021 Nov; 35(9):947-955. PubMed ID: 34464462
[TBL] [Abstract][Full Text] [Related]
18. Making waves: How does the emergence of antimicrobial resistance affect policymaking?
Maganha de Almeida Kumlien AC; González-Villalobos E; Balcázar JL
Water Res; 2021 Nov; 206():117772. PubMed ID: 34688095
[TBL] [Abstract][Full Text] [Related]
19. BSAC Vanguard Series: Inequality and antibiotic resistance.
Mendelson M
J Antimicrob Chemother; 2022 Feb; 77(2):277-278. PubMed ID: 35107142
[TBL] [Abstract][Full Text] [Related]
20. The Pandemic beyond the Pandemic: A Scoping Review on the Social Relationships between COVID-19 and Antimicrobial Resistance.
Toro-Alzate L; Hofstraat K; de Vries DH
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
